Inovio Pharmaceuticals
INO
#9200
Rank
HK$0.83 B
Marketcap
HK$12.16
Share price
-3.11%
Change (1 day)
-21.15%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.44. In 2024 the company made an earnings per share (EPS) of -HK$30.78 an increase over its 2023 EPS that were of -HK$47.45.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-27.07%
2024-HK$30.78-35.14%
2023-HK$47.45-56.62%
2022-HK$109.40-19.54%
2021-HK$135.9735.9%
2020-HK$100.05-11.57%
2019-HK$113.1415.24%
2018-HK$98.18-2.78%
2017-HK$100.986.93%
2016-HK$94.44134.88%
2015-HK$40.21-29.51%
2014-HK$57.04-57.34%
2013-HK$133.71146.55%
2012-HK$54.2320.83%
2011-HK$44.88-29.41%
2010-HK$63.58-48.48%
2009-HK$123.4310%
2008-HK$112.2011.11%
2007-HK$100.98-41.3%
2006-HK$172.05-66.91%
2005-HK$519.88110.61%
2004-HK$246.85-61.63%
2003-HK$643.31186.67%
2002-HK$224.41
2001N/A-100%
2000-HK$179.53-63.64%
1999-HK$493.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$13.40-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.34-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-HK$9.74-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.35-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$59.17-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$28.02-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
HK$50.80-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA